Outlook Therapeutics Stock (NASDAQ: OTLK) stock price, news, charts, stock research, profile.
You can purchase shares of Outlook Therapeutics (NASDAQ:OTLK) through any online brokerage.
Other companies in Outlook Therapeutics’s space includes: Skye Bioscience (NASDAQ:SKYE), Innate Pharma (NASDAQ:IPHA), Cabaletta Bio (NASDAQ:CABA), Anixa Biosciences (NASDAQ:ANIX) and Adverum Biotechnologies (NASDAQ:ADVM).
Outlook Therapeutics has a consensus price target of $21.95.
The stock price for Outlook Therapeutics (NASDAQ: OTLK) is $5 last updated November 26, 2024 at 4:50 PM EST.
There are no upcoming dividends for Outlook Therapeutics.
Outlook Therapeutics’s Q1 earnings are confirmed for Wednesday, February 12, 2025.
There is no upcoming split for Outlook Therapeutics.
Outlook Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.